Intelligent Bio Solutions Reports 8.8% Increase in Shares Outstanding from Warrant Exercises and ATM Sales
Summary
Intelligent Bio Solutions Inc. updated its shares outstanding, reporting an 8.8% increase to 2,176,848 shares as of April 20, 2026, due to warrant exercises and sales under its existing At-The-Market offering program.
Key Events
-
Shares Outstanding Update
The company reported 2,176,848 shares of common stock outstanding as of April 20, 2026.
-
Significant Dilution
This represents an increase of 175,675 shares, or approximately 8.8%, since March 3, 2026, resulting from warrant exercises and sales under its At-The-Market (ATM) offering program.
-
Investor Presentation Furnished
The company also furnished an investor presentation, providing an overview of its business and operations, accessible on its website.
Analysis
This 8-K filing provides a material update on the company's capital structure, detailing a significant increase in outstanding shares. The issuance of 175,675 new shares since March 3, 2026, from warrant exercises and sales through the At-The-Market (ATM) program, represents substantial dilution for existing shareholders. While this dilution is negative, it also indicates the company is actively utilizing its existing capital programs to address liquidity needs, which is critical given its previously disclosed "going concern" warning. Investors should monitor the ongoing use of the ATM program and its impact on future share count and financial stability.
At the time of this filing, INBS was trading at $2.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $2.42 to $24.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.